Medicare prescriptions for Wegovy jumped after approval for heart disease

Medicare prescriptions for Wegovy jumped after approval for heart disease. Medicare prescriptions for Wegovy increased sharply after the program started covering the anti-obesity medication to prevent heart problems, but just a fraction of beneficiaries likely eligible received the treatment, according to new research published in the American Journal of Managed Care by the USC Schaeffer Center for Health Policy & Economics.

A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.

Trechos de apoio da pauta: Medicare prescriptions for Wegovy increased sharply after the program started covering the anti-obesity medication to prevent heart problems, but just a fraction of beneficiaries likely eligible received the treatment, according to new research published in the American Journal of Managed Care by the USC Schaeffer Center for Health Policy & Economics.

• Ponto de atenção: medicare.
• Ponto de atenção: prescriptions.
• Ponto de atenção: wegovy.

Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.